AGM/EGMJun 10, 2026, 04:23 PM
Astrana Health Shareholders Approve 2024 Equity Plan, Elect Directors
AI Summary
Astrana Health, Inc. held its Annual Meeting on June 10, 2026, where stockholders approved the Amended and Restated 2024 Equity Incentive Plan. This plan increases the shares reserved for issuance by 1,000,000 and extends its term until March 24, 2036. Additionally, nine directors were elected to the Board, the appointment of Ernst & Young LLP as the independent auditor was ratified, and the executive compensation program received advisory approval.
Key Highlights
- Stockholders approved the Amended and Restated 2024 Equity Incentive Plan.
- Shares reserved for the 2024 Plan increased by 1,000,000 shares.
- The 2024 Plan's term was extended until March 24, 2036.
- Nine directors were elected to the Board until the 2027 Annual Meeting.
- Ernst & Young LLP's appointment as independent auditor for 2026 was ratified.
- The executive compensation program received advisory approval.
- A quorum was established with 43,772,595 shares, representing 78.6% of outstanding votes.
Price Impact
More from ASTH